Literature DB >> 22982119

Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists.

Jung-Chen Su1, Kuen-Feng Chen, Wei-Lin Chen, Chun-Yu Liu, Jui-Wen Huang, Wei-Tien Tai, Pei-Jer Chen, Inki Kim, Chung-Wai Shiau.   

Abstract

Obatoclax is a linear oligopyrrole compound which antagonizes the antiapoptotic effects of the Bcl-2 family. Herein we describe the synthesis of obatoclax derivatives by replacement of the pyrrole and indole ring of obatoclax with thiophene, furan and thiazolidinedione. The in vitro cytotoxicity of the newly synthesized compounds is evaluated against hepatocellular carcinoma cells. Pyrrole and indole substituents of obatoclax analogues exhibited potent inhibition of cell growth. Among the tested compounds, 5d and 5e were active at 6.3 and 13.2 μM against PLC5 cells. Further assays confirmed a correlation between cell death, and p-STAT3 inhibition and SHP-1 activation by these analogues.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982119     DOI: 10.1016/j.ejmech.2012.08.024

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  RFX1-dependent activation of SHP-1 induces autophagy by a novel obatoclax derivative in hepatocellular carcinoma cells.

Authors:  Jung-Chen Su; Ping-Hui Tseng; Cheng-Yi Hsu; Wei-Tien Tai; Jui-Wen Huang; Ching-Huai Ko; Mai-Wei Lin; Chun-Yu Liu; Kuen-Feng Chen; Chung-Wai Shiau
Journal:  Oncotarget       Date:  2014-07-15

2.  Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.

Authors:  Chun-Yu Liu; Jung-Chen Su; Tzu-Ting Huang; Pei-Yi Chu; Chun-Teng Huang; Wan-Lun Wang; Chia-Han Lee; Ka-Yi Lau; Wen-Chun Tsai; Hsiu-Ping Yang; Chung-Wai Shiau; Ling-Ming Tseng; Kuen-Feng Chen
Journal:  Mol Oncol       Date:  2017-02-07       Impact factor: 6.603

3.  The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells.

Authors:  Chun-Yu Liu; Tzu-Ting Huang; Pei-Yi Chu; Chun-Teng Huang; Chia-Han Lee; Wan-Lun Wang; Ka-Yi Lau; Wen-Chun Tsai; Tzu-I Chao; Jung-Chen Su; Ming-Huang Chen; Chung-Wai Shiau; Ling-Ming Tseng; Kuen-Feng Chen
Journal:  Exp Mol Med       Date:  2017-08-11       Impact factor: 8.718

4.  Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1.

Authors:  Jung-Chen Su; Chuan-Hsun Chang; Szu-Hsien Wu; Chung-Wai Shiau
Journal:  J Enzyme Inhib Med Chem       Date:  2018-12       Impact factor: 5.051

Review 5.  Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers.

Authors:  Vivek Kaushik; Juan Sebastian Yakisich; Anil Kumar; Neelam Azad; Anand K V Iyer
Journal:  Cancers (Basel)       Date:  2018-09-27       Impact factor: 6.639

Review 6.  BH3-mimetics: recent developments in cancer therapy.

Authors:  Paul A Townsend; Maria V Kozhevnikova; Olivier N F Cexus; Andrey A Zamyatnin; Surinder M Soond
Journal:  J Exp Clin Cancer Res       Date:  2021-11-09

Review 7.  Prodigiosin: a promising biomolecule with many potential biomedical applications.

Authors:  German A Islan; Boris Rodenak-Kladniew; Nehuen Noacco; Nelson Duran; Guillermo R Castro
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

8.  Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cells.

Authors:  Chun-Yu Liu; Kuen-Feng Chen; Tzu-I Chao; Pei-Yi Chu; Chun-Teng Huang; Tzu-Ting Huang; Hsiu-Ping Yang; Wan-Lun Wang; Chia-Han Lee; Ka-Yi Lau; Wen-Chun Tsai; Jung-Chen Su; Chia-Yun Wu; Ming-Huang Chen; Chung-Wai Shiau; Ling-Ming Tseng
Journal:  J Mol Med (Berl)       Date:  2017-06-04       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.